Journal article

Androstenedione is the preferred androgen source in hormone refractory prostate cancer-Response

CM Hovens, MKH Hong, NM Corcoran

Clinical Cancer Research | AMER ASSOC CANCER RESEARCH | Published : 2014

DOI: 10.1158/1078-0432.CCR-14-1536

University of Melbourne Researchers

Christopher Hovens Author

Niall Corcoran Author

Citation metrics

1Web of Science

Keywords

3202 Clinical Sciences

Life Sciences & Biomedicine

3211 Oncology and Carcinogenesis

Science & Technology

32 Biomedical and Clinical Sciences